Autologous bone marrow purging by lymphokine-activated killer cells: rationale and prospects.
Nasr
S
S
Department of Pediatrics, Emory University, Atlanta, Ga.
Sabio
H
H
Ades
E W
EW
D001853:Bone Marrow / Q000276:immunology / Q000473:pathology*; D016026:Bone Marrow Transplantation; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic; D005069:Evaluation Studies as Topic; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000276:immunology*; D008212:Lymphocyte Depletion; D014182:Transplantation, Autologous; D014407:Tumor Cells, Cultured; D014410:Tumor Stem Cell Assay
D007376:Interleukin-2